FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

781492009: Dacomitinib (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3747351018 Dacomitinib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3747352013 Dacomitinib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
375011000195115 dacomitinib it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
1133721000241119 dacomitinib fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dacomitinib Is a Quinazoline (substance) true Inferred relationship Some
Dacomitinib Is a Piperidine true Inferred relationship Some
Dacomitinib Is a Protein-tyrosine kinase inhibitor true Inferred relationship Some
Dacomitinib This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Protein-tyrosine kinase inhibitor (disposition) true Inferred relationship Some
Dacomitinib Is a Enzyme inhibitor false Inferred relationship Some
Dacomitinib Is a Antineoplastic agent (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Dacomitinib only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dacomitinib Inferred relationship Some 1
Dacomitinib-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dacomitinib Inferred relationship Some 1
Dacomitinib-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dacomitinib Inferred relationship Some 1
Dacomitinib only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dacomitinib Inferred relationship Some 1
Dacomitinib 15 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dacomitinib Inferred relationship Some 1
Dacomitinib 15 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dacomitinib Inferred relationship Some 1
Dacomitinib monohydrate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Dacomitinib Inferred relationship Some
Dacomitinib 30 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dacomitinib Inferred relationship Some 1
Dacomitinib 30 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dacomitinib Inferred relationship Some 1
Dacomitinib 45 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dacomitinib Inferred relationship Some 1
Dacomitinib 45 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dacomitinib Inferred relationship Some 1
Dacomitinib anhydrous (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Dacomitinib Inferred relationship Some

This concept is not in any reference sets

Back to Start